021-51111890
购物车（）
sales@molnova.cn
Aurintricarboxylic acid
CAS No. 4431-00-9
Aurintricarboxylic acid ( ATA | NSC-4056 | NSC 4056 | NSC4056 )
产品货号. M24401 CAS No. 4431-00-9
金三羧酸是拓扑异构酶和其他核酸酶的强抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ￥294 | 有现货 |
|
| 100MG | ￥410 | 有现货 |
|
| 200MG | ￥597 | 有现货 |
|
| 500MG | ￥972 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥170 | 有现货 |
|
生物学信息
-
产品名称Aurintricarboxylic acid
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述金三羧酸是拓扑异构酶和其他核酸酶的强抑制剂。
-
产品描述Aurintricarboxylic acid is a strong inhibitor of topoisomerases and other nucleases. It is a potent inhibitor of ribonuclease and topoisomerase II by preventing the binding of the nucleic acid to the enzyme.
-
体外实验Western Blot Analysis Cell Line:T98G, A172, GBM44 glioma cells Concentration:10 μM Incubation Time:0.5 hour, 1 hour, 2 hours Result:Abrogated TWEAK activation of downstream signals including phosphorylation of the NF-κB family member p65, Akt, and Src in all three GBM cell lines.
-
体内实验——
-
同义词ATA | NSC-4056 | NSC 4056 | NSC4056
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis|MicroRNA|rP2X1|rP2X3|Topoisomerase II
-
研究领域——
-
适应症——
化学信息
-
CAS Number4431-00-9
-
分子量422.35
-
分子式C22H14O9
-
纯度>98% (HPLC)
-
溶解度DMSO:125 mg/mL (295.97 mM; Need ultrasonic)
-
SMILESOC(c(cc(cc1)C(c(cc2)cc(C(O)=O)c2O)=C(C=C2)C=C(C(O)=O)C2=O)c1O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Liu T T , Yang T , Gao M N , et al. The inhibitory mechanism of aurintricarboxylic acid targeting serine/threonine phosphatase Stp1 in Staphylococcus aureus: insights from molecular dynamics simulations[J]. Acta Pharmacologica Sinica, 2019.
产品手册
关联产品
-
RAPTA-C
RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
-
Lanperisone HCl
Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.Lanperisone HCl acts by inducing non-apoptotic cell death in the cell cycle and translational independence.
-
Simmiparib
Simmiparib 是一种高效且具有口服活性的 PARP1 和 PARP2 抑制剂，IC50 分别为 1.75 nM 和 0.22 nM。Simmiparib 对 PARP1/2 的抑制作用强于其母体化合物 Olaparib (HY-10162)。在同源重组修复 (HR) 缺陷细胞中，Simmiparib 诱导 DNA 双链断裂 (DSB) 积累和 G2/M 阻滞，从而诱导细胞凋亡 (apoptosis)。Simmiparib 在细胞和裸鼠移植瘤模型中都表现出显著的抗癌活性。
